197 related articles for article (PubMed ID: 15794868)
1. Cold agglutinin disease and cryoglobulinemia.
Gertz MA
Clin Lymphoma; 2005 Mar; 5(4):290-3. PubMed ID: 15794868
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide.
Bhattacharyya J; Mihara K; Takihara Y; Kimura A
Ann Hematol; 2012 May; 91(5):797-799. PubMed ID: 21901341
[No Abstract] [Full Text] [Related]
3. Severe cold agglutinin disease and cryoglobulinemia secondary to a monoclonal anti-Pr2 IgM lambda cryoagglutinin.
Ciejka JZ; Cook EB; Lawler D; Martin J; Woodson RD; Graziano F
Clin Exp Rheumatol; 1999; 17(2):227-31. PubMed ID: 10342051
[TBL] [Abstract][Full Text] [Related]
4. [Cryoglobulinemia].
Cacoub P; Sène D; Saadoun D
Rev Med Interne; 2008 Mar; 29(3):200-8. PubMed ID: 18242787
[TBL] [Abstract][Full Text] [Related]
5. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
Iannuzzella F; Garini G
Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
[TBL] [Abstract][Full Text] [Related]
6. Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab.
Ruch J; McMahon B; Ramsey G; Kwaan HC
Am J Hematol; 2009 Feb; 84(2):120-2. PubMed ID: 19097173
[TBL] [Abstract][Full Text] [Related]
7. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
Ahmed MS; Wong CF
J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy.
Mori A; Tamaru J; Sumi H; Kondo H
Eur J Haematol; 2002 Apr; 68(4):243-6. PubMed ID: 12071942
[TBL] [Abstract][Full Text] [Related]
9. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.
Roccatello D; Baldovino S; Rossi D; Giachino O; Mansouri M; Naretto C; Di Simone D; Francica S; Cavallo R; Alpa M; Napoli F; Sena LM
Clin Rev Allergy Immunol; 2008 Feb; 34(1):111-7. PubMed ID: 18270864
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Delluc A; Piette JC; Cacoub P
Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis C-virus-related glomerulonephritis.
Kamar N; Rostaing L; Alric L
Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
[TBL] [Abstract][Full Text] [Related]
12. Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia.
Gertz MA
Hematol Oncol Clin North Am; 2022 Apr; 36(2):341-352. PubMed ID: 35282954
[TBL] [Abstract][Full Text] [Related]
13. Cold hemolytic syndrome.
Gertz MA
Hematology Am Soc Hematol Educ Program; 2006; ():19-23. PubMed ID: 17124034
[TBL] [Abstract][Full Text] [Related]
14. Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab.
Braun A; Neumann T; Oelzner P; Hein G; Gröne HJ; Ziemer M; Wolf G
Rheumatol Int; 2008 Mar; 28(5):503-6. PubMed ID: 17924113
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus-related heat-insoluble cryoglobulinemia and thrombotic microangiopathy.
Wu H; Zou HB; Xu Y; Zhang L; Du YJ; Yu JY; Lu RH; Li X
Am J Med Sci; 2013 Oct; 346(4):345-8. PubMed ID: 23744520
[TBL] [Abstract][Full Text] [Related]
16. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.
Fabrizi F; Plaisier E; Saadoun D; Martin P; Messa P; Cacoub P
Am J Kidney Dis; 2013 Apr; 61(4):623-37. PubMed ID: 23102733
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure.
Ghijsels E; Lerut E; Vanrenterghem Y; Kuypers D
Am J Kidney Dis; 2004 May; 43(5):e34-8. PubMed ID: 15112197
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in cryoglobulinemic peripheral neuropathy.
Cavallo R; Roccatello D; Menegatti E; Naretto C; Napoli F; Baldovino S
J Neurol; 2009 Jul; 256(7):1076-82. PubMed ID: 19263187
[TBL] [Abstract][Full Text] [Related]
20. Cryoglobulins Today: Detection and Immunologic Characteristics of 1,675 Positive Samples From 13,439 Patients Obtained Over Six Years.
Kolopp-Sarda MN; Nombel A; Miossec P
Arthritis Rheumatol; 2019 Nov; 71(11):1904-1912. PubMed ID: 31136095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
